title: The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future projects.
abstract: Boron Neutron Capture Therapy (BNCT) is an experimental treatment modality that takes place in a nuclear research reactor. To progress from preclinical studies to patient treatment is a challenge requiring strict quality management and special solutions to licensing, liability, insurance, responsibility and logistics. The European Organisation for the Research and Treatment of Cancer (EORTC) BNCT group has started the first European clinical trial of BNCT for glioblastoma patients at the European High Flux Reactor (HFR) in Petten, The Netherlands, conducted by the Department of Radiotherapy of the University of Essen, Germany. A very strict quality management had to be installed following the European rules on safety and quality assurance for nuclear research reactors, for radioprotection, for radiotherapy and for clinical trials. The EORTC BNCT Group has created a virtual European-wide hospital to handle the complex management of patients treated with BNCT. New clinical trials are currently under development.
authors.affiliation: Strahlenklinik, University of Essen, Hufelandstrasse 55 D-45122, Essen, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Sauerwein
authors.forename: A
authors.initials: A
authors.lastname: Zurlo
mesh_terms: D016754:Boron Neutron Capture Therapy / Q000592:standards* / Q000639:trends; D001932:Brain Neoplasms / Q000532:radiotherapy*; D002986:Clinical Trials as Topic / Q000592:standards; D005060:Europe; D005544:Forecasting; D005909:Glioblastoma / Q000532:radiotherapy*; D006801:Humans; D007390:International Agencies / Q000458:organization & administration* / Q000639:trends; D008495:Medical Oncology / Q000458:organization & administration* / Q000639:trends; D011786:Quality Control